SpIntellx
Michael Becich has a long and distinguished career in the field of biomedical informatics. Michael began their career in 1991 as Chairman and Distinguished University Professor of the Department of Biomedical Informatics at the University of Pittsburgh School of Medicine. During their tenure, they increased the department's research funding to $15M per year and launched a robust pipeline of STEMM (STEM in Medicine) programs. In 2015, they became Associate Vice Chancellor of the University of Pittsburgh School of Medicine and Co-Director of the Center for Commercial Applications of Healthcare Data at the Pittsburgh Health Data Alliance. In 2008, they joined the Scientific Advisory Board of Omnyx/GE Healthcare, a joint venture of the University of Pittsburgh Medical Center and GE Healthcare focused on digital pathology solutions. In 2016, they joined the Board of Scientific Advisors of the National Cancer Institute. In 2018, they founded SpIntellx, Inc. and in 2022 they became Co-Director of the Pittsburgh Supercomputing Center.
Michael Becich received their BS in Biology Psychology from Northwestern University in 1977. Michael then went on to pursue a MD PhD in Experimental Pathology at Northwestern University - The Feinberg School of Medicine, which they completed in 1984. From 1984 to 1989, they completed a residency in Anatomic Pathology at Washington University School of Medicine in St. Louis.
This person is not in the org chart
This person is not in any teams
SpIntellx
SpIntellx harnesses the computational power of proprietary unbiased spatial analytics, spatial systems pathology, and explainable artificial intelligence (xAI) to extract information from patient primary disease pathology samples to create predictive knowledge that is required to develop personalized therapeutic strategies, identify potential novel targets for drug discovery, optimally select patient cohorts for clinical trials and improve the predictive power of prognostics/diagnostics.